The dominant market consensus around an 85–90 cumulative influenza-associated hospitalization rate for Week 21, 2026, reflects CDC FluSurv-NET surveillance data showing steady accumulation through the season's peak and shoulder weeks. Weekly rates have fallen sharply from highs above 12 per 100,000 in late December 2025 to just 0.2 per 100,000 by Week 18 in mid-May, pushing the cumulative total to 86.3 per 100,000 with only modest further gains expected amid low transmission. Official estimates place total season hospitalizations near 380,000, consistent with a moderately severe H3N2-dominated season that ranks among the higher cumulative burdens since 2010–2011. Minimal new admissions forecasted through early June support the narrow band, though final resolution remains subject to routine data revisions and any late-season reporting adjustments from the surveillance network.
Polymarketデータを参照したAI生成の実験的な要約。これは取引アドバイスではなく、このマーケットの解決方法には一切関係ありません。 · 更新日Flu Hospitalization Rate Week 21, 2026?
85–90 100.0%
<80 <1%
80–85 <1%
90–95 <1%
$5,474 Vol.
$5,474 Vol.
<80
No
80–85
No
85–90
Yes
90–95
No
95–100
No
100+
No
85–90 100.0%
<80 <1%
80–85 <1%
90–95 <1%
$5,474 Vol.
$5,474 Vol.
<80
No
80–85
No
85–90
Yes
90–95
No
95–100
No
100+
No
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
マーケット開始日: Jun 1, 2026, 12:42 PM ET
Resolver
0x69c47De9D...提案された結果: No
異議申し立てなし
最終結果: No
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
Resolver
0x69c47De9D...提案された結果: No
異議申し立てなし
最終結果: No
The dominant market consensus around an 85–90 cumulative influenza-associated hospitalization rate for Week 21, 2026, reflects CDC FluSurv-NET surveillance data showing steady accumulation through the season's peak and shoulder weeks. Weekly rates have fallen sharply from highs above 12 per 100,000 in late December 2025 to just 0.2 per 100,000 by Week 18 in mid-May, pushing the cumulative total to 86.3 per 100,000 with only modest further gains expected amid low transmission. Official estimates place total season hospitalizations near 380,000, consistent with a moderately severe H3N2-dominated season that ranks among the higher cumulative burdens since 2010–2011. Minimal new admissions forecasted through early June support the narrow band, though final resolution remains subject to routine data revisions and any late-season reporting adjustments from the surveillance network.
Polymarketデータを参照したAI生成の実験的な要約。これは取引アドバイスではなく、このマーケットの解決方法には一切関係ありません。 · 更新日
外部リンクに注意してください。
外部リンクに注意してください。
よくある質問